Pinnacle Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404M Sell
1,652,666
-7,377
-0.4% -$1.72M 5.19% 1
2025
Q4
$344M Buy
1,660,043
+73
+0% +$14.4K 4.41% 1
2025
Q3
$308M Sell
1,659,970
-345,156
-17% -$59.1M 4.08% 2
2025
Q2
$306M Sell
2,005,126
-2,182,271
-52% -$335M 4.43% 1
2025
Q1
$694M Sell
4,187,397
-1,823,484
-30% -$285M 10.18% 1
2024
Q4
$869M Buy
6,010,881
+4,703,577
+360% +$729M 11.79% 1
2024
Q3
$205M Buy
1,307,304
+29,597
+2% +$4.72M 3.48% 2
2024
Q2
$187M Sell
1,277,707
-26,821
-2% -$3.99M 2.92% 3
2024
Q1
$206M Sell
1,304,528
-2,776
-0.2% -$442K 3.25% 2
2023
Q4
$205M Buy
1,307,304
+1,141
+0.1% +$175K 3.45% 2
2023
Q3
$203M Sell
1,306,163
-2,846
-0.2% -$470K 3.78% 2
2023
Q2
$217M Buy
1,309,009
+21,178
+2% +$3.42M 3.76% 2
2023
Q1
$200M Sell
1,287,831
-3,902
-0.3% -$630K 4.08% 2
2022
Q4
$228M Sell
1,291,733
-1,576
-0.1% -$272K 4.97% 1
2022
Q3
$211M Buy
1,293,309
+400,462
+45% +$67.8M 4.85% 1
2022
Q2
$158M Buy
892,847
+8,547
+1% +$1.52M 3.46% 2
2022
Q1
$157M Sell
884,300
-3,998
-0.5% -$680K 2.77% 3
2021
Q4
$152M Buy
888,298
+44,006
+5% +$7.2M 2.62% 3
2021
Q3
$136M Sell
844,292
-596
-0.1% -$102K 2.51% 2
2021
Q2
$139M Buy
844,888
+4,493
+0.5% +$744K 2.52% 2
2021
Q1
$138M Sell
840,395
-2,121
-0.3% -$343K 2.63% 2
2020
Q4
$133M Buy
842,516
+93,493
+12% +$13.8M 2.69% 3
2020
Q3
$112M Buy
749,023
+100,199
+15% +$14.8M 2.65% 2
2020
Q2
$91.2M Buy
648,824
+108,894
+20% +$15.9M 2.25% 3
2020
Q1
$70.8M Buy
539,930
+313,283
+138% +$44.4M 2.15% 3
2019
Q4
$33.1M Buy
226,647
+10,902
+5% +$1.48M 0.72% 33
2019
Q3
$27.9M Buy
215,745
+3,295
+2% +$434K 0.66% 40
2019
Q2
$29.6M Sell
212,450
-232
-0.1% -$32.1K 0.69% 39
2019
Q1
$29.7M Sell
212,682
-22,359
-10% -$2.99M 0.67% 40
2018
Q4
$30.3M Buy
235,041
+1,283
+0.5% +$179K 0.78% 26
2018
Q3
$32.3M Buy
233,758
+1,805
+0.8% +$240K 0.67% 38
2018
Q2
$28.1M Buy
231,953
+13,956
+6% +$1.74M 0.58% 49
2018
Q1
$27.9M Buy
217,997
+11,273
+5% +$1.52M 0.55% 49
2017
Q4
$28.9M Buy
206,724
+4,223
+2% +$588K 0.55% 53
2017
Q3
$26.3M Sell
202,501
-3,725
-2% -$494K 0.49% 63
2017
Q2
$27.3M Sell
206,226
-959
-0.5% -$122K 0.52% 53
2017
Q1
$25.8M Sell
207,185
-19,795
-9% -$2.36M 0.49% 56
2016
Q4
$26.1M Sell
226,980
-4,380
-2% -$506K 0.53% 53
2016
Q3
$27.3M Buy
231,360
+5,573
+2% +$676K 0.55% 52
2016
Q2
$27.4M Buy
225,787
+20,264
+10% +$2.3M 0.59% 47
2016
Q1
$22.2M Sell
205,523
-7,860
-4% -$814K 0.48% 59
2015
Q4
$21.9M Buy
213,383
+6,409
+3% +$645K 0.46% 65
2015
Q3
$19.3M Sell
206,974
-1,792
-0.9% -$173K 0.43% 64
2015
Q2
$20.3M Sell
208,766
-18,184
-8% -$1.82M 0.38% 76
2015
Q1
$22.8M Sell
226,950
-2,947
-1% -$300K 0.43% 66
2014
Q4
$24M Buy
229,897
+1,425
+0.6% +$150K 0.47% 59
2014
Q3
$24.4M Sell
228,472
-2,269
-1% -$235K 0.5% 58
2014
Q2
$24.1M Sell
230,741
-4,542
-2% -$459K 0.47% 58
2014
Q1
$23.1M Sell
235,283
-10,711
-4% -$993K 0.45% 62
2013
Q4
$22.5M Buy
245,994
+15,326
+7% +$1.41M 0.44% 63
2013
Q3
$20M Sell
230,668
-2,156
-0.9% -$193K 0.41% 68
2013
Q2
$20M Buy
+232,824
New +$19.8M 0.45% 67

Other funds holding JNJ

Pinnacle Associates's JNJ Position: Q1 2026 in Review

Pinnacle Associates reduced its Johnson & Johnson (JNJ) stake by 0.44% in Q1 2026, selling an estimated $1.72M and leaving 1,652,666 shares worth $404M. The position accounts for 5.19% of the portfolio, ranked #1.

Pinnacle Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $869M in Q4 2024. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pinnacle Associates held 1,652,666 shares of Johnson & Johnson worth $404M as of Q1 2026.
  • Pinnacle Associates sold 7,377 Johnson & Johnson shares in Q1 2026, an estimated $1.72M.
  • Johnson & Johnson made up 5.19% of Pinnacle Associates's portfolio in Q1 2026, its #1 holding.
  • Pinnacle Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's Johnson & Johnson position peaked at $869M in Q4 2024.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.